ISSN : ISSN: 0975-9344
International Journal of Drug Development and Research (IJDDR) publishes full length research reports, review articles,and scientific commentaries & communication on all aspects of the pharmaceutical sciences with strong sciences with strong emphasis on novelty, originality and scientific quality. The Editors welcome articles in this multidisciplinary field, ranging from Drug Development to Drug Discovery.
More specifically, the Journal publishes reports in medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery systems including gene delivery, drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. This is further ratified by the Google Analytics metrics that analyses and releases our reader’s profile from time to time and the total number of page views are 18,00,000.
A statistical representation of global users for International Journal of Drug Development and Research (Source: Google Analytics)
A statistical representation of global users for International Journal of Drug Development and Research (Source: Google Analytics)
iMedPub was established in the year 2005 and since then has been actively publishing peer-reviewed articles in biomedical and clinical science; material science; mathematics and engineering topics. iMedPub follows standard editorial and production policies with Internationally acclaimed publication practices.
Due to wide variation in the journal portfolio, the publisher site is accessed by various communities of diverse scientific disciplines from reputed research organizations, academic institution and Government bodies. More than 6,781,894 users have accessed the publisher website with more than 17,950,990 page views. These stats reveal that the journal is also immensely popular among scientific societies and organizations. Consequently, the editorial board profiles, authors and their affiliations are also gaining higher visibility.
The number of web sessions, the publisher received was 8,509,611 at the rate of 2.11 new sessions. This implied that new users and visitors are flocking to the publisher bases. A number of users are also revisiting the publisher pages indicating their continued interest in the journal. The fast and efficient publishing standard set by iMedPub was found to be very impressive by the reader base and is being well appreciated; as evident from the web metrics. The metric displayed belong only to our journals and if the associated links are also taken into consideration the number would be significantly much higher.